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Abstract
Sustained nutrient (fuel) excess, as occurs during obesity and diabetes, has been linked to increased inflammation, impaired 
mitochondrial homeostasis, lipotoxicity, and insulin resistance in skeletal muscle. Precisely how mitochondrial dysfunction 
is initiated and whether it contributes to insulin resistance in this tissue remains a poorly resolved issue. Herein, we examine 
the contribution that an increase in proinflammatory NFkB signalling makes towards regulation of mitochondrial bioenerget-
ics, morphology, and dynamics and its impact upon insulin action in skeletal muscle cells subject to chronic fuel (glucose 
and palmitate) overloading. We show sustained nutrient excess of L6 myotubes promotes activation of the IKKβ-NFkB 
pathway (as judged by a six-fold increase in IL-6 mRNA expression; an NFkB target gene) and that this was associated with 
a marked reduction in mitochondrial respiratory capacity (>50%), a three-fold increase in mitochondrial fragmentation and 
2.5-fold increase in mitophagy. Under these circumstances, we also noted a reduction in the mRNA and protein abundance 
of PGC1α and that of key mitochondrial components (SDHA, ANT-1, UCP3, and MFN2) as well as an increase in cellular 
ROS and impaired insulin action in myotubes. Strikingly, pharmacological or genetic repression of NFkB activity amelio-
rated disturbances in mitochondrial respiratory function/morphology, attenuated loss of SDHA, ANT-1, UCP3, and MFN2 
and mitigated the increase in ROS and the associated reduction in myotube insulin sensitivity. Our findings indicate that 
sustained oversupply of metabolic fuel to skeletal muscle cells induces heightened NFkB signalling and that this serves as a 
critical driver for disturbances in mitochondrial function and morphology, redox status, and insulin signalling.




FAs  Free fatty acids
DAG  Diacylglycerol
NFKB  Nuclear factor kappa-light-chain-enhancer of 
activated B cells
IL6  Interleukin-6
TNF  Tumor necrosis factor-α
IKKβ  Inhibitor of nuclear factor kappa-B kinase subu-
nit beta
IKBα  Inhibitor of nuclear factor kappa-B
ROS  Reactive oxygen species
ANT-1  Adenine nucleotide translocase type 1
UCP3  Uncoupling protein 3
SDHA  Succinate Dehydrogenase
PGC1α  Peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha
MitoQ  Mitoquinone
TLR-4  Toll-like receptor-4
2DG  2-Deoxyglucose
FCCP  Carbonilcyanide 
p-trifluromethoxyphenylhydrazone
OPA1  Optic atrophy 1
MFN2  Mitofusin 2
DRP1  Dynamin-related protein 1
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Introduction
There is mounting evidence that chronic activation of 
proinflammatory signalling in tissues such as skeletal 
muscle and adipose is a significant contributing factor in 
the development and progression of metabolic disorders 
such as insulin resistance, obesity and Type II diabetes 
[1, 2]. This inflammatory response is triggered by circu-
lating proinflammatory cytokines such as interleukin-6 
(IL-6), tumour necrosis factor-α (TNFα) and by sustained 
increases in the concentration of free fatty acids (FAs), 
such as palmitate. The actions of these stimuli serve to 
not only further induce tissue expression and secretion 
of IL-6 and TNFα (via the NFκB pathway, [3, 4]), but 
impair control of numerous signalling pathways regulat-
ing skeletal muscle insulin signalling, glucose uptake, 
mitochondrial fuel oxidation and respiration that impact 
negatively upon skeletal muscle energy homeostasis [2, 
5–7]. Indeed, mitochondrial dysfunction and/or a reduc-
tion in mitochondrial content, as characterised by a fall in 
oxidative capacity, has been reported in skeletal muscle 
and adipose tissue from obese and diabetic subjects [8, 
9]. Notably, the sustained oversupply of metabolic fuel 
(glucose and fatty acids) to skeletal muscle, as seen dur-
ing Type II diabetes and obesity, impairs the ability of 
mitochondria to shift between use of lipid during fasting 
and use of carbohydrate in the post-prandial state. This 
metabolic inflexibility imposes a major substrate burden 
on the oxidative machinery of muscle and the continued 
oversupply of carbon fuel eventually surpasses the respira-
tory drive and cellular demand for ATP synthesis [10]. As 
a result, FAs undergo incomplete oxidation and greater 
partitioning into lipotoxic derivatives [e.g., diacylglycerol 
(DAG) and ceramides] which have been strongly impli-
cated in the pathogenesis of insulin resistance [11, 12]. 
Whilst some have suggested that sufficient mitochondrial 
capacity remains under such circumstances [13], others 
submit that without energy demand such capacity is irrel-
evant and that metabolic dysfunction associated with the 
“effective” mitochondrial insufficiency may exacerbate 
effects of lipotoxicity [14–18].
Mitochondrial fuel overload also increases produc-
tion of reactive oxygen species (ROS) [19, 20] that may 
serve to trigger or prime mechanisms that not only induce, 
but also sustain the loss in mitochondrial function. For 
example, it is has been suggested that increased ROS 
generation may suppress expression of PGC1α (a major 
regulator of mitochondrial biogenesis) and that of genes 
encoding components of the respiratory chain, but may 
also act as a stimulus activating proinflammatory NFkB 
signalling that intersects with processes influencing mito-
chondrial function [21, 22]. In support of this latter idea, 
signalling initiated by toll-like receptor-4 (TLR-4) and 
the tumor necrosis factor-α (TNF-α) receptor results in 
activation of the NFkB pathway, which has been linked to 
reduced mitochondrial respiration and suppressed activa-
tion of transcriptional regulators that promote mitochon-
drial biogenesis and the shift towards a muscle oxidative 
phenotype [23, 24]. We, and others, have also previously 
demonstrated that obesity in rodents and chronic oversup-
ply of metabolic fuel to skeletal muscle cells in vitro is 
associated with an increase in proinflammatory NFkB sig-
nalling and insulin resistance [17, 25, 26]. We hypothesise 
that sustained oversupply of metabolic fuel will promote 
activation of proinflammatory NFkB signalling in mus-
cle cells and that this contributes significantly to distur-
bances in mitochondrial biology that impact negatively 
upon myocellular insulin sensitivity. The studies reported 
herein have tested this proposition.
Materials and methods
Chemicals and reagents
Culture media α-MEM (α-minimum essential medium), 
DMEM (Dulbecco’s Modified Eagle’s medium), Medium 
199, foetal bovine serum, horse serum, Mitosox, prolong 
diamond antifade mountant, and mitotracker dyes were all 
purchased from Thermo Fisher Scientific (UK). α-MEM 
media-lacking glucose was purchased from PAN Biotech, 
UK, Mitoquinone (Mito Q) was obtained from Cambridge 
biosciences, UK). BI605906 was a generous gift from Pro-
fessor Sir Philip Cohen (MRC Protein Phosphorylation Unit, 
University of Dundee), but also purchased from Tocris (Bris-
tol, UK), MitoSpy™ Green FM was from BioLegends, UK 
and MitoPYI, Mitotempo, hepatocyte growth factor, dexa-
methasone, basic FGF, gelatine, vitamin B12, retinoic acid, 
VAS2870, palmitate, oligomycin, FCCP (carbonyl cyanide 
p-trifluoromethoxyphenylhydrazone), rotenone, antimycin-
A, hygromycin B, apo-transferrin human,  SYBR® Green 
JumpStart Taq Ready Mix, and Polyberen were all purchased 
Sigma-Aldrich, UK).
Rat and human skeletal muscle cell culture, 
transfection and fatty acid treatment
L6 muscle cells were cultured to myotubes as described 
previously [27] in α-minimal essential media (αMEM) 
containing 2% (v/v) foetal bovine serum (FBS) and 1% 
(v/v) antibiotic/antimycotic solution (100 units/ml penicil-
lin, 100 μg/ml streptomycin, and 250 ng/ml amphotericin 
B) at 37 °C with 5%  CO2. In some experiments, L6 myo-
tubes were infected with adenovirus harbouring a mutated 
IκBαS32A/S36A construct. This virus was kindly provided 
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by Dr Harry Heimberg (Vrije Universiteit Brussel, Belgium) 
and was initially propagated in HEK293 cells and stored at 
– 80 °C. The viral titre was determined by standard plaque 
assay in HEK293 cells. Confluent mononucleated L6 myo-
blasts were infected with the adenovirus at 5.5 pfu/cell for 
IκBαS32A/S36A in serum free α-MEM for 2 h at 37 °C. 
Cells were subsequently maintained in fresh α-MEM con-
taining 2% FBS at 37 °C and allowed to differentiate into 
myotubes prior to experimental use. For some studies, we 
also used human (LHCN-M2) myotubes. These were cul-
tured in DMEM/M199 medium (4:1) supplemented with 
penicillin streptomycin (100 μg/ml), FBS 15% (v/v) HEPES 
(20 mM), Zinc sulphate (30 ng/ml), vitamin B12 (1.4 μg/
ml), dexamethasone (55 ng/ml), hepatocyte growth factor, 
recombinant human (2.5 ng/ml), and basic FGF (10 ng/ml) 
on plastic ware that had been coated overnight with gelatin 
(0.1% (w/v) at room temperature. Confluent myotubes were 
differentiated by change of culture media to DMEM/medium 
199 containing zinc sulphate, HEPES, vitamin B12, insulin 
(10 μg/ml), and apotransferrin (100 μg/ml) and refreshing 
this every 48 h for 9–10 days until myotubes were 70–80% 
differentiated.
Prior to use in experiments, L6 myotubes were incubated 
in serum-containing media that either had or lacked d-glu-
cose (5 mM) as indicated in the figures. For palmitate (PA) 
treatments, a 100 mM stock solution of the fatty acid was 
prepared in absolute ethanol as previously reported [28, 29]. 
This stock was subsequently diluted to a final concentra-
tion as indicated in the figure legends by addition to culture 
media containing 2% (w/v) fatty acid-free BSA and allowed 
to precomplex for 1 h at 37 °C before being applied onto 
myotubes for the periods indicated in the figure legends.
Quantitative real‑time PCR, mitochondrial DNA 
quantification, and analysis of citrate synthase 
activity
Myotubes were incubated with glucose, palmitate, and 
2-dexoglucose (2DG) or with inhibitors and/or fluores-
cent dyes as indicated in the figure legends and prepared 
for RNA extraction, qPCR analysis, and immunoblotting as 
described previously [17, 25, 30, 31]. Briefly, total RNA 
was extracted from L6 myotubes using the TRizol extrac-
tion protocol (Thermo Fisher Scientific, UK). RNA samples 
were used to prepare cDNA using a qScript cDNA synthe-
sis kit as per manufacturer’s instructions and cDNA quanti-
fied using the real-time PCR Syber Green based method 
to establish mRNA abundance. Analysis of mitochondrial 
DNA (mtDNA) and citrate synthase activity were used as 
a proxy for mitochondrial mass. For mtDNA quantifica-
tion, total DNA was extracted from L6 myotubes using a 
Qiagen DNaesy kit. The mtDNA was quantified by qPCR 
using primers directed against the mitochondrial ND4 
gene and the nuclear-encoded COX4 gene and using the 
Syber Green method. Data were expressed as a ratio of the 
∆∆Ct ND4 to the ∆∆Ct of COX4. The forward and reverse 
primer sequences for the different gene targets are detailed 
in Table 1. Citrate synthase (CS) activity was measured 
using a kit purchased from Sigma-Aldrich/UK (MAK193). 
Myotubes were treated as indicated in the figure legend 
and whole cell extracts prepared at the end of the appro-
priate treatments. 20 μg protein from the cell extract was 
used for each enzymatic analysis (with measurements being 
conducted in triplicate for each experimental determina-
tion at room temperature). Enzyme activity was measured 
spectrophotometrically (using an absorbance wavelength 
of 412 nm) using a µQUNT BIOTEK plate reader from 
LabTech UK with readings taken every 3 min over a 60 min 
assay period. CS activity was calculated as per manufac-
turer’s instructions.
Subcellular fractionation
A mitochondrial-enriched membrane fraction was iso-
lated from L6 myotubes using a mitochondria isolation kit 
(#89874, Thermo Fisher Scientific) as per manufacturer’s 
instructions. The methodological protocol involves homog-
enisation of myotubes that have been harvested from 10 cm 
tissue culture plates having undergone prior experimental 
treatments as indicated in the appropriate figure legends in 
lysis buffer [10 mM HEPES, PH 7.5, 10 mM KCl, 0.1 mM 
EDTA, 0.1 mM DTT, 0.5% (v/v) Nonidet-P40 and 0.5 mM 
Table 1  Primer sequences GENE Forward primer Reverse primer
SDHA GCC ACT CAC TCT TAC ACA CC GCA CTC CCC ATT TTC CAT C
UCP3 GTC AAG CAG TTC TAC ACC CC TTT CCT CTC GCC TCC AGT TC
ANT1 TCA TCT ACA GAG CTG CCT AC TCA TCA TCC TAC GAC GGA C
IL6 AGC CAC TGC CTT CCC TAC TT GCC ATT GCA CAA CTC TTT TCTC 
ND4 GAG GCA ACC AAA CAG AAC GC ATC ATG TTG AGG GTA GGG GGT 
COX4 AAT GTT GGC TAC CAG GGC AC GGG TAG TCA CGC CGA TCA AC
β-ACTIN TGG AGA AGA TTT GGC ACC ACAC CAG AGG CAT ACA GGG ACA ACAC 
PGC1α TGA ACT ACG GGA TGG CAA C AAG AGC AAG AAG GCG ACA C
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PMSF and protease inhibitor cocktail]. The homogenised 
cell material was subject to two differential centrifugation 
steps and within the final centrifugation step the resulting 
mitochondrial pellet was washed twice prior to being solu-
bilised in RIPA buffer. The supernatant from the final spin 
(cytosolic fraction) and the solubilised mitochondrial mem-
brane pellet were stored at – 20 ºC until required.
For isolation of nuclear membranes, L6 myotubes were 
grown on 10 cm dishes as described above and, after treat-
ments, washed three times in PBS before being harvested 
and spun down in a microfuge (100 g for 5 min). The cell 
pellet was resuspended in lysis buffer and held on ice for 
20 min with intermittent mixing prior to being centrifuged 
at 10,000 g for 5 min. The resulting supernatant represents 
a cytosolic fraction. The pelleted nuclei were washed three 
times in lysis buffer before being resuspended in nuclear 
extraction buffer (20 mM HEPES PH 7.5, 400 mM NaCl, 
1 mM EDTA, 1 mM DTT, 1 mM PMSF with protease inhib-
itor cocktail) and re-spun at 10,000g for 15 min at 4 °C. The 
resulting nuclear pellet was resuspended in fresh extraction 
buffer and stored at – 20 °C until required.
SDS‑PAGE and immunoblotting
Cell lysates, cytosolic, nuclear, or mitochondrial-enriched 
fractions (20 μg protein) from L6 myotubes and human 
LHCN-M2 myotubes were subjected to SDS/PAGE on 10% 
resolving gels and transferred onto nitrocellulose membranes 
(Millipore, Harts, UK), as described previously [27]. Mem-
branes were probed with the following primary antibod-
ies for immunoblot analysis: actin (#A5060) and tubulin 
(#T6074) were obtained from Sigma: ANT-1 (#ab180715) 
and PGC1α (#ab54481) were from Abcam; IkBα (#SC-
371), SDHA (#SC98253), and GAPDH (#SC32233) were 
purchased from Santa Cruz; p65 (#8242), Akt (#9272), 
p-AktSer473 (#9271S), TOM20 (# 42406S), HA (#2367S), 
COX4 (#4580S), and GPX1 (# 3286S) and SOD2 (#D9V9C) 
were all purchased from Cell Signalling Technology; DLP1/
Drp1 (#611112) and OPA1 (#612607) were from BD Bio-
sciences; and UCP3 (#GTX112699) from Genetex. Pri-
mary antibody detection was performed using appropriate 
horse-radish peroxidase (HRP) conjugated secondary mouse 
(#7076S) or rabbit (#7074S) antibodies were purchased from 
Cell Signalling Technology and visualised using enhanced 
chemiluminescence (Pierce-Perbio Biotech, Tattenhall, UK) 
on Kodak X-OMAT film (Eastman-Kodak, Rochester, UK). 
The immunoreactive protein bands were quantified using 
ImageJ software.
Glucose uptake
L6 myotubes were incubated with glucose, palmitate and 
BI605906 for times and at concentrations indicated in the 
figure legends prior to assaying uptake of 10 μM 2-deoxy-
d-[3H]-glucose as described previously [27]. Non-specific 
binding was determined by quantifying cell-associated radi-
oactivity in the presence of 10 μM cytochalasin B. Cells 
were washed and subsequently lysed in 50 mM NaOH and 
radioactivity quantified by scintillation counting. Protein 
concentration in cell lysates was determined using the Brad-
ford reagent [32].
ROS quantification
For analysis of superoxide, L6 myotubes were subject to 
experimental treatments as indicated in the figure legends 
prior to being treated with 5 μM Mitosox at 37°C in a 5% 
 CO2 incubator for 30 min. Mitosox is a fluorogenic dye that 
is specifically targeted to mitochondria in live cells, and 
whose oxidation by superoxide produces red fluorescence 
that was quantified using a Clario Star plate reader with 
absorption/emission maxima: 510/585 nm. In some experi-
ments, L6 myotubes were also treated with Mitotempo (a 
mitochondrial targeted anti-oxidant) prior to analysis of 
superoxide.
For determination of hydrogen peroxide  (H2O2) under 
live cell conditions, L6 myotubes were incubated with 5 μM 
MitoPYI (a mitochondrial targeted  H2O2 probe) and 1 μM 
deep red cell tracker at 37 °C in a 5%  CO2 incubator for 
45 min. Myotubes were subsequently imaged using a Zeiss 
confocal microscope with excitation/emission maxima for 
MitoPYI set to 488/530 nm and that for the cell tracker at 
633/647 nm. Captured images were analysed to quantify the 
fluorescent signal generated by MitoPYI from at least 8–10 
different visual fields (40–50 myotubes) per condition per 
experiment using ImageJ software.
Analysis of cellular respiration and mitochondrial 
energetics
For analysis of cellular respiration and mitochondrial ener-
getics in L6 and LHCN-M2 myotubes, we used a Seahorse 
XF24 analyser. L6 myotubes were cultured on Seahorse cul-
ture plates in serum-containing media supplemented with 
5 mM d-glucose and/or palmitate at concentrations indicated 
in the figure legends for 16 h. In some experiments, the cul-
ture media were also supplemented with 5 mM 2-deoxyglu-
cose (2-DG), BI605906 (IKKβ inhibitor) or 2 mM carnitine 
as indicated prior to analysis of basal respiration, ATP-
linked respiration, H+ (proton) leak, maximal respiratory 
capacity and non-mitochondrial respiration using modula-
tors of cellular respiration (i.e., oligomycin, FCCP (carbonyl 
cyanide p-trifluoromethoxyphenylhydrazone), rotenone, and 
antimycin as previously described [33]. The various mito-
chondrial parameters were normalised to protein content/
well within the Seahorse plate. For Seahorse XF analyser 
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studies, data points per experimental condition were col-
lected from a minimum of three replicates with each experi-
ment being conducted at least three times.
Mitochondria morphology and live cell 
mitochondrial imaging
For analyses of mitochondrial morphology, we stained L6 
myotubes with Mitospy Green FM (BioLegend, UK); a 
green-fluorescent stain that localizes to mitochondria. L6 
myotubes were grown on 15  mm2 glass coverslips and fol-
lowing the experimental treatments specified in the figure 
legends were washed with fresh media and subsequently 
incubated in medium containing 300 nM Mitospy for 30 min 
at 37°C in a 95%  O2/5%  CO2 environment. After this incuba-
tion period, myotubes were washed with PBS prior to being 
fixed with 2% (w/v) paraformaldehyde and mounted in pro-
longed diamond antifade before being visualised using a 
Zeiss confocal microscope. Live cell imaging was also used 
in some of our studies. For these, L6 or LHCN-M2 myotubes 
were grown and differentiated in eight well chamber slide 
plates (Ibidia, UK) and having been treated (as indicated 
in the figure legends) were washed with fresh phenol red-
free media prior to incubation with Mitospy. Mitochondrial 
morphology was then visualised in real time using Zeiss 
confocal microscope 37 °C in a 5%  CO2 chamber with exci-
tation/emission set at 480 nm and 520 nm, respectively. For 
real-time recording of mitochondrial length, we used the 
ZEISS ZEN microscope software or Image J. Within each 
experimental condition, at least 50 myotubes were randomly 
selected from between 10 and 12 visual fields. Mitochon-
drial morphology within myotubes was categorised as either 
spheroid/fragmented in which mitochondria were equal to 
or less than 1 μm in length or tubular/elongated (including 
being part of a network), where mitochondrial length was 
greater than 1 μm. The number of mitochondria in each cat-
egory within the fields being visualised was then determined 
and expressed as a percentage.
Analysis of mitophagy
Mitophagy was quantified using the mitophagy QC approach 
[34], which involves stable expression of a tandem mCherry-
GFP tag attached to the outer mitochondrial membrane 
localization signal of Fis1 (residues 101–152) [34]. The 
retrovirus harbouring this construct was introduced into 
L6 myotubes using the approach detailed previously [35]. 
The L6-GFP–mCherry cells were grown and differenti-
ated on 15 mm2 cover slips and subjected to the treatments 
detailed in the figure legends prior to being washed and 
fixed with 3.7% cell culture grade paraformaldehyde and 
mounted in prolonged diamond antifade. Cells were visu-
alised using Zeiss 710 confocal microscope. Myotubes 
expressing the mCherry-GFP construct fluoresce red and 
green (yellow when confocal images are merged). However, 
upon increased mitophagy, mitochondria are delivered to 
lysosomes, where the low pH quenches the GFP signal but 
not mCherry. Consequently, some of the mitochondria form 
punctate structures and fluoresce red only and the degree of 
mitophagy calculated by quantitating their increase using 
the volocity software.
Statistical analysis
Statistical analysis was performed using the GraphPad 
Prism version 7 software using one-way analysis of variance 
(ANOVA) and Tukey post hoc test for multiple comparisons. 
Values were considered significant at P < 0.05.
Results
Effects of palmitate oversupply on proinflammatory 
signalling, ROS generation and mitochondrial 
function in myotubes
In an attempt to establish the relationship between changes 
in proinflammatory NFkB signalling, ROS generation, and 
mitochondrial biology, we initially investigated the effects 
of modulating palmitate (PA) provision on these param-
eters. L6 myotubes were incubated in α-MEM containing 
a physiological (5 mM) d-glucose (GLC) concentration 
in the absence and the presence of increasing concentra-
tions of palmitate (PA; 0.1–0.5 mM) for 16 h. At the end of 
this period, the abundance of IkBα and expression of IL-6 
mRNA were monitored as readouts of NFkB signalling. 
Figure 1a, b shows that myotubes exposed to increasing PA 
concentrations exhibit a dose-dependent reduction in cel-
lular IkBα abundance that was associated with a concomi-
tant increase in IL-6 gene expression. Since the threshold 
concentration at which PA induced a significant change in 
IkBα and IL-6 gene expression was 0.4 mM, all subsequent 
experiments involving nutrient overloading of myotubes 
were conducted in the presence of 5 mM GLC and 0.4 mM 
PA unless otherwise indicated. It is important to stress that 
combined provision of GLC and PA at these concentrations 
did not invoke any notable death or loss of terminally dif-
ferentiated myotubes on culture plates.
A characteristic feature associated with mitochondrial 
fuel overload is increased cellular ROS [e.g., superoxide 
(O2–.) and hydrogen peroxide  (H2O2)], whose generation 
can promote oxidative damage and metabolic dysfunc-
tion. Whilst incubation of myotubes with 5 mM GLC or 
0.4 mM PA alone had no significant effect on ROS produc-
tion in myotubes, the combined presence of both nutrients 
induced a significant increase in O2–. and  H2O2 (Fig. 1c, d). 
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The notion that this increase in ROS is driven by nutri-
ent overload is strengthened by our demonstration that 
increases in O2–. and  H2O2 are regulated in a PA and GLC 
concentration-dependent manner (Supplementary Fig. S1 
and S2) and that increases in ROS can be restrained in 
myotubes exposed to 2-deoxyglucose (2DG); a glycolytic 
inhibitor that severely restricts GLC use as a metabolic 
fuel (Fig. 1c, d; Supplementary Fig. S1 and S2). Fur-
thermore, we contest that the increase in ROS, we see in 
response to GLC/PA overloading is principally mitochon-
drial generated given that treating myotubes with either 
Mitotempo or MitoQ, two mitochondrial targeted anti-
oxidants, which, respectively, scavenge O2–. and quench 
 H2O2, effectively suppress increases in both ROS initiated 
by fuel oversupply (Supplementary Fig. S1D and S2D).
For analysis of real-time mitochondrial respiration in 
myotubes, we utilised a Seahorse extracellular flux ana-
lyser that measures oxygen consumption rates (OCR) 
before and after addition of compounds that target Com-
plexes I and III of the respiratory chain, the ATP syn-
thase or which function to uncouple mitochondrial oxi-
dative phosphorylation (OXPHOS) to allow analysis of 
numerous mitochondrial parameters. Figure 1e–h shows 
that compared to myotubes incubated with either 5 mM 
GLC or 0.4 mM PA alone, those exposed to both carbon 
fuels simultaneously had a lower OCR and also exhibited 
Fig. 1  Cellular fuel overloading induces NFkB inflammatory signal-
ling, ROS (superoxide and  H2O2) production and mitochondrial dys-
function. L6 myotubes were incubated with glucose (GLC, 5  mM) 
in the absence and presence of palmitate (PA) at doses indicated for 
16 h prior to analysis of (a) cellular IkBα abundance by immunoblot-
ting and b IL6 and β-actin mRNA abundance by qPCR. For analysis 
of superoxide (c) and  H2O2 (d) L6 myotubes were treated as in (a) 
with PA (0.4 mM) for 16 h in absence or presence GLC (5 mM) and/
or 2-deoxyglucose (2DG, 5  mM) as indicated followed by quantifi-
cation of ROS using 5 μM of either Mitosox or MitoPYI as detailed 
in methods. For analysis of real-time cellular respiration in L6 myo-
tubes we used a Seahorse XF24 analyser. L6 myotubes were incu-
bated for 16 h with either GLC (5 mM) or PA (0.4 mM) alone, PA 
(0.4 mM)/GLC (5 mM) together or with a mixture of PA (0.4 mM)/
GLC (5 mM)/2DG (5 mM). Oligomycin (1 μM), FCCP (1 μM) and 
a rotenone (1 μM)/antimycin-A (2 μM) mix were added at times indi-
cated by dotted lines on the Seahorse trace. The trace shown in (e) 
is a representative readout of oxygen consumption rate (OCR) from 
a single experiment with measurements (mean ± SD) of triplicate 
values. Analysis of absolute basal mitochondrial OCR normalised to 
protein/well (f), coupling efficiency of oxidative phosphorylation (g, 
determined as the oligomycin sensitivity fraction of the basal respira-
tory rate) and (h) the respiratory capacity ratio (calculated as a factor 
of the FCCP-stimulated respiration/oligomycin resistance). The data 
shown in (f–h) is the combined analyses of three separate experi-
ments. All data are presented as mean ± SEM. Asterisks indicate a 
significant change (P < 0.05) to the GLC alone condition or between 
the indicated bars
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a significant reduction in basal respiration, OXPHOS cou-
pling, and respiratory capacity. Strikingly, these respira-
tory changes are averted in myotubes incubated in media 
containing GLC and PA, but to which 2DG was also added 
to inhibit glucose use as a metabolic substrate. To further 
demonstrate that this amelioration most likely reflects a 
lowering of mitochondrial substrate load rather than a 
reduction in substrate competition, we assessed the impact 
of increasing the PA concentration in the absence of any 
GLC. Figure 2a shows that whilst the OCR was compara-
ble when myotubes were incubated with either 5 mM GLC 
or 0.4 mM PA alone and co-provision of GLC and PA at 
these concentrations induced a significant decline in basal 
respiration, this reduction could also be recapitulated in 
myotubes incubated with PA alone, but when presented at 
a higher concentration (0.7 mM) to increase mitochondrial 
substrate load. It is also important to stress that incubation 
of myotubes with PA was conducted in serum-containing 
media in which carnitine was present at physiological 
concentrations. Consequently, we believe it unlikely that 
carnitine would be limiting for mitochondrial uptake and 
oxidation of PA at the concentrations used in our studies. 
In line with this view, exogenous supplementation of car-
nitine (2 mM) to culture media did not enhance or ame-
liorate the reduction in mitochondrial respiratory capacity 
that we see in PA/GLC treated myotubes (Fig. 2b).
Effects of mitochondrial fuel overload and glycolytic 
inhibition on mitochondrial morphology
The data presented in Fig. 1e–h imply that chronic over-
supply of metabolic fuel (GLC + PA) to myotubes impairs 
mitochondrial respiration and that this can be mitigated 
when use of GLC as a metabolic fuel was restricted using 
2DG as a glycolytic inhibitor. To test whether the reduced 
respiratory function assayed under fuel-overload conditions 
was associated with changes in mitochondrial morphology, 
we subsequently performed live cell imaging to visualise 
mitochondria using Mitotracker Green. The dye is excluded 
from nuclei, but accumulates within mitochondria and con-
sequently helps depict the syncytial nature of differentiated 
L6 myotubes used in our study. Strikingly, in myotubes 
that had been incubated with GLC or PA alone, the green-
fluorescent mitochondrial dye highlights that ~ 80% of the 
mitochondrial population is part of an organised elongated/
tubular network, which becomes structurally fragmented 
and spheroid in nature when myotubes are subjected to 
a sustained period of fuel overloading with GLC and PA 
(Fig. 3a, b). In line with the finding that glycolytic inhibition 
with 2DG helps preserve mitochondrial respiratory function 
(Fig. 1e–h), the morphological change in the mitochondrial 
network caused by substrate overloading was mitigated by 
2DG (Fig. 3).
Fig. 2  Effect of glucose/palmi-
tate overloading and carnitine 
supplementation on mitochon-
drial function in L6 myotubes. 
L6 myotubes were incubated 
with glucose (GLC, 5 mM), 
palmitate (PA, 0.4 mM or 
0.7 mM) or with GLC (5 mM) 
and PA (0.4 mM) together for 
16 h as shown in (a) or in some 
experiments (b) when treated 
with GLC and PA together 
such treatments were done in 
the presence of either carnitine 
(2 mM) or 2-deoxyglucose 
(2DG, 5 mM) prior to analysis 
of real-time cellular respiration 
using a Seahorse XF24 analyser. 
All data are presented as mean 
± SEM. Asterisks indicate a 
significant change (P < 0.05) 
between the indicated bars. NS 
signifies no significant change
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Is proinflammatory NFkB signalling a driver of ROS 
generation in response to nutrient overloading?
To explore whether the increase in NFkB signalling seen 
in myotubes subjected to nutrient overload is a contribut-
ing factor to mitochondrial ROS production and respiratory 
dysfunction, we applied two distinct but complimentary 
strategies. The first utilised BI605906, a potent pharmaco-
logical inhibitor that shows high selectivity for IKKβ  (IC50 
= 380 nM) when tested against over 100 kinases in a panel 
screen [36], whereas the second involved adenoviral medi-
ated expression of a mutant form of IκBα (S32A/S36A) that 
functions as a super-repressor of NFκB activity [25]. Muta-
tion of Ser32 and Ser36 to alanine renders IκBα resistant to 
IKK phosphorylation, thereby protecting it from proteasomal 
degradation and retaining its capacity to hold NFκB in an 
inhibited state. To test the effectiveness of each strategy, we 
initially assayed the ability of BI605906 and the IκBαS32A/
S36A mutant to suppress NFkB activation in response to 
nutrient overload in L6 myotubes. The data in Fig. 4a, b 
show that the reduction in IkBα instigated by a 16 h period 
of nutrient (GLC + PA) overloading in myotubes was halted 
by BI605906 or by cellular expression of the IkBα mutant. 
Moreover, consistent with this observation, both BI605906 
and IκBαS32A/S36A expression attenuated nuclear localisation 
of the p65 subunit of NFkB and reduced transcription of the 
IL-6 gene (an NFkB target gene) that is otherwise seen in 
GLC+PA-overloaded myotubes (Fig. 4c, d).
Analysis of ROS production in L6 myotubes revealed 
that in the absence of PA provision, BI605906 per se has 
no detectable effect upon cellular O2–. or  H2O2, but signifi-
cantly reduces the increase in both species when myotubes 
were subjected to chronic nutrient oversupply (Fig.  5a, 
b). Similarly, repressing NFkB activation by expression 
of IκBαS32A/S36A blocked the increase in ROS triggered 
by nutrient overload (Fig. 5c, d). It is noteworthy that this 
Fig. 3  Effect of glucose/palmitate overloading on mitochondrial 
morphology in L6 myotubes. L6 myotubes were incubated for 16 h 
with either GLC (5  mM) or PA (0.4  mM) alone, PA (0.4  mM)/
GLC (5  mM) together or with a mixture of PA (0.4  mM)/GLC 
(5 mM)/2DG (5 mM) prior to staining with Mitotracker green (Mito-
spy) and confocal microscopy. a Confocal images depict mitochon-
drial morphology in L6 myotubes (the scale bar represents 5  μm). 
Nuclei (N) are labelled and white boxed areas are magnified to show 
differences in morphology. The arrow heads depict fragmented mito-
chondria. b Mitochondrial length was quantified using the imaging 
software and presented as elongated/tubular if greater than 1 μm and 
fragmented if < 1 μm in length. Data are presented as mean + SEM 
from a minimum of three separate experiments. Asterisks indicate a 
significant change (P < 0.05) between the black filled bars, whereas 
the hash (#) indicates a significant difference (P < 0.05) between the 
grey filled bars
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nutrient-induced increase in ROS is accompanied by an 
attendant increase in the expression of anti-oxidant enzymes 
[superoxide dismutase 2 (SOD2), catalase and glutathione 
peroxidase (GPX1)], which most likely forms part of a cel-
lular defence mechanism designed to help limit oxidative 
damage/stress under these circumstances (Supplementary 
Fig. S2E). Intriguingly, however, whilst the elevated ROS 
generation induced by cellular over-nutrition was restrained 
by BI605906 (Fig. 5a, b), the inhibitor did not to suppress 
the increased expression of SOD2, catalase or GPX1 (Sup-
plementary Fig. S2E), suggesting that expression of these 
enzymes was likely to be regulated by mechanisms that are 
distinct to those involved in promoting generation of  O2– and 
 H2O2.
Is increased NFkB signalling a causal factor 
for mitochondrial dysfunction in myotubes 
during nutrient overload?
Impaired mitochondrial bioenergetics can result in the exces-
sive generation of ROS during the process of OXPHOS. 
Since inhibition of NFkB signalling suppresses the increase 
in cellular ROS associated with nutrient overload, we sub-
sequently tested whether this might be linked to improved 
mitochondrial function. The data in Fig. 6 show the effects of 
inhibiting NFkB signalling in L6 myotubes (using BI605906 
and by cellular expression of the IκBαS32A/S36A super-repres-
sor) upon mitochondrial function. In line with the findings 
presented in Fig. 1e–h, sustained (16 h) exposure of myo-
tubes to nutrient excess (GLC and PA) induced a significant 
decline in the basal and maximal respiratory rate, which was 
associated with a reduction in ATP-linked respiration and 
a modest decline in mitochondrial proton leak (Fig. 6a–j). 
Strikingly, these nutrient-induced disturbances in mito-
chondrial respiration were ameliorated if activation of the 
IKKβ-NFkB signalling axis by nutrient excess was repressed 
by BI605906 in a dose-dependent manner (Fig. 6a–e and 
Supplementary Fig. S3) or expression of the IκBαS32A/S36A 
mutant (Fig. 6f–j). Notably, the improved respiratory drive 
that we see under these circumstances is associated with a 
significant increase in mitochondrial proton leak (Fig. 6e, j) 
potentially signifying increased mitochondrial uncoupling 
that would also help offset ROS generation.
Effects of repressing NFkB signalling 
on mitochondrial morphology and expression 
of proteins important for mitochondrial function
To assess whether the improved respiratory capacity that was 
seen upon inhibiting NFkB signalling in nutrient-overloaded 
Fig. 4  Effects of suppressing NFkB on inflammatory signal-
ling induced by nutrient overload in L6 myotubes. a L6 myotubes 
were incubated for 16  h with either GLC (5  mM) or PA (0.4  mM) 
alone, PA (0.4 mM)/GLC (5 mM) together or with a mixture of PA 
(0.4 mM)/GLC (5 mM)/2DG (5 mM) in the absence or presence of 
BI605906 (10  μM), an IKKβ inhibitor prior to analysis of cellular 
IkBα abundance by immunoblotting. b L6 myoblasts were infected 
with an adenoviral vector expressing HA-tagged non-phosphorylata-
ble IkBα (S32A/S36A) or one expressing an empty vector (EV). Cells 
were allowed to differentiate prior to treatment of cells with GLC, 
PA and 2DG and analysis of IkBα abundance as described in (a). L6 
myotubes were treated with GLC (5 mM), PA (0.4 mM), BI605906 
(10 μM) and adenoviral vectors as indicated prior to (c) subcellular 
fractionation and analyses of cytosolic and nuclear NFkB p65 abun-
dance by immunoblotting or d analysis of IL-6 gene expression. All 
data are presented as mean ± SEM from a minimum of three sepa-
rate experiments. Asterisks indicate a significant change (P < 0.05) 
between the indicated bars
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myotubes was associated with changes in mitochondrial mor-
phology or mitochondrial mass we subsequently performed 
live cell imaging of mitochondria stained with Mitotracker 
Green and also assessed cellular mitochondrial DNA con-
tent. Figure 7a shows that repressing NFkB signalling with 
BI605906 helps attenuate the fragmentation of the elongated/
tubular mitochondrial network that is otherwise seen when 
myotubes are chronically exposed to nutrient excess. qPCR 
analysis was used to determine mitochondrial DNA copy 
number by quantifying the relative abundance of the mito-
chondrial encoded NADH dehydrogenase 4 (ND4) gene to 
that of COX4 (a nuclear-encoded gene). Figure 7b, c shows 
that irrespective of whether myotubes were subject to nutri-
ent overload or not, or whether they were treated with 2DG 
or BI605906, we observed no significant differences in mito-
chondrial DNA or citrate synthase activity (a representative 
nuclear-encoded mitochondrial enzyme) in response to the 
various experimental manipulations. Both these measures are 
considered a proxy of mitochondrial mass.
Whilst mitochondrial mass in L6 myotubes was unaltered 
following a 16 h period of nutrient overload, the reduced 
respiratory rate seen under these circumstances was associ-
ated with a significant reduction in the abundance of proteins 
with key roles in mitochondrial bioenergetics. These include 
uncoupling protein 3 (UCP3), mitochondrial ADP–ATP trans-
locase (ANT1) and succinate dehydrogenase (SDHA) as well 
as PGC1α, which has a major role in regulating mitochondrial 
biogenesis and function (Fig. 7d). Our analysis reveals that the 
decline in these proteins may have been driven by a decrease 
in gene expression based on the reduced mRNA abundance 
that, respectively, encode the four proteins (Fig. 7e). Whilst 
we saw no change in the protein abundance of Cox 4.1 (a 
subunit of Cytochrome C-oxidase that functions within the 
mitochondrial respiratory chain) in myotubes exposed to both 
GLC and 0.4 mM PA, we have shown previously that its cel-
lular abundance declines dramatically when the presence of 
PA in GLC-containing media is raised above 0.4 mM [17, 
31]. This latter finding may potentially signify that the expres-
sion and stability of Cox4.1 may have a slightly higher toler-
ance for nutrient stress than some of the other mitochondrial 
proteins that we have investigated. Significantly, however, the 
loss seen in UCP3, ANT1, SDHA, and PGC1α protein in fuel-
overloaded myotubes was ameliorated by not only pharma-
cological repression of the IKKβ-NFkB signalling axis with 
BI605906, but also by restraining GLC metabolism using 2DG 
(Fig. 7d, e).
It is plausible that the increased respiratory drive seen 
in myotubes that have been subject to fuel overloading, but 
in which activation of the NFkB pathway has been blunted 
(Fig. 6) is a benefit derived from suppressing mitochondrial 
ROS production (Fig. 5). However, our analysis indicates 
that whilst exposing myotubes to two distinct mitochondrial 
targeted anti-oxidants (Mitotempo and Mito Q) limits frag-
mentation of the mitochondrial network induced by nutri-
ent oversupply, neither compound could rescue the loss in 
UCP3, ANT1, or PGC1α expression or prevent the decline 
in mitochondrial respiratory capacity (Supplementary Fig. 
S4). However, we did see some recovery in the expression 
of SDHA. We are mindful that ROS production can also 
occur at extra-mitochondrial sites such as via NADPH oxi-
dase (NOXII) in the cytosol, but targeting NOXII with a 
cell permeable inhibitor, VAS2870, also proved ineffective 
in countering the decline in respiratory capacity caused by 
nutrient excess (Supplementary Fig. S4).
Effects of mitochondrial substrate overload 
on mitophagy
Since chronic oversupply of metabolic fuel promotes 
mitochondrial dysfunction, we postulated that under such 
Fig. 5  Effects of NFkB antagonism on ROS production. a, b L6 
myotubes were incubated for 16  h with either GLC (5  mM) or PA 
(0.4 mM) alone, PA (0.4 mM)/GLC (5 mM) together in the absence 
or presence of BI605906 (10 μM) or subject to these treatments hav-
ing been infected with an adenoviral vector expressing HA-tagged 
non-phosphorylatable IkBα (S32A/S36A) or one expressing an empty 
vector (EV) c, d prior to analysis of superoxide and hydrogen perox-
ide. All data are presented as mean ± SEM from four separate experi-
ments. Asterisks indicate a significant change (P < 0.05) between the 
indicated bars
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circumstances, there might be an increase in mitophagy to 
help clear damaged/dysfunctional mitochondria. To test 
this hypothesis, we initially monitored expression of pro-
teins implicated in the control of mitochondrial dynamics 
in a mitochondrial-enriched membrane fraction isolated 
from myotubes that had been subject to fuel overloading 
in the absence and presence of BI605906. Figure 8a shows 
that sustained exposure of myotubes to 5 mM GLC and 
0.4 mM PA induced a very modest increase in the mito-
chondrial abundance of Drp1, a GTPase that facilitates 
mitochondrial fission. This increase in mitochondrial-
associated Drp1 may have resulted from its recruitment 
from a cytoplasmic pool, which showed a corresponding 
decline in its abundance. By contrast, we noted a loss in 
mitochondrial mitofusin 2 (MFN2), a GTPase resident on 
the outer mitochondrial membrane involved in mitochon-
drial clustering and fusion (Fig. 8a). The relative changes 
in mitochondrial Drp1 and MFN2 is consistent with a 
shift in mitochondrial dynamics that favours increased 
fission and would be in line with our morphological anal-
ysis (Fig. 7a). In contrast, the observed changes in mito-
chondrial-associated Drp1 and MFN2 abundance were 
repressed in fuel-loaded myotubes that had been treated 
with BI605906 and would fit with the reduced mitochon-
drial fragmentation that we see (Fig. 7a). No notable dif-
ferences were observed for mitofusin 1 (MFN1) or optic 
Fig. 6  Effect of suppressing NFkB activation in response to cellu-
lar fuel overloading on mitochondrial respiration. a–e L6 myotubes 
were incubated for 16  h with either GLC (5  mM) or PA (0.4  mM) 
alone, PA (0.4 mM)/GLC (5 mM) together in the absence or presence 
of BI605906 (10 μM) or f–j subject to these treatments having been 
infected with an adenoviral vector expressing HA-tagged non-phos-
phorylatable IkBα (S32A/S36A) or one expressing an empty vector 
(EV) prior to analysis of real-time cellular respiration in L6 myotubes 
using a Seahorse XF24 analyser. Oligomycin (1 μM), FCCP (1 μM) 
and a rotenone (1 μM)/antimycin-A (2 μM) mix were added at times 
indicated by dotted lines. a, f show representative readouts of oxy-
gen consumption rate (OCR) from a single experiment with meas-
urements (mean ± SD) of triplicate values. b, g Depict basal mito-
chondrial oxygen consumption rate (OCR), c, h maximal respiration 
(OCR after FCCP stimulation), d, i ATP-linked respiration (oligomy-
cin-sensitive OCR) and e–j proton leak (oligomycin resistance rate). 
Data are presented as mean ± SEM from five independent experi-
ments. Asterisks indicate a significant change (P < 0.05) between the 
indicated bars
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atrophy-1 protein (OPA-1) in the mitochondrial and cyto-
solic fractions that we examined (Fig. 8a).
To assess whether increased fragmentation/fission in 
response to nutrient excess also increases mitophagy, we 
utilised myotubes stably expressing a tandem mCherry-
GFP tag attached to the outer mitochondrial membrane 
localization signal of Fis1 (residues 101–152) [34]. Fig-
ure 8b, c shows representative field images that high-
light (red) the presence of mitophagic objects in myo-
tubes incubated with GLC or PA alone, which most 
likely reflects basal mitophagy (see arrow heads within 
the magnified regions from the box inserts). Whilst this 
approach does not quantitatively assess mitophagic flux, 
it indicates that the combined provision of GLC and PA 
induces a significant increase in mitophagic particles 
(Fig. 8d, f) whose appearance is restrained upon cotreat-
ment of myotubes with BI605906 (Fig. 8e, f).
Effects of suppressing NFkB signalling 
in substrate‑loaded myotubes on insulin sensitivity
A number of previous studies have shown that sustained 
exposure of muscle cells to nutrient (glucose and fatty acid) 
excess impairs insulin action and have linked this to dis-
turbances in mitochondrial function. To assess whether 
preserving the respiratory capacity and integrity of the 
mitochondrial network in nutrient overloaded myotubes by 
inhibition of NFkB signalling improves insulin action, we 
assessed insulin-stimulated Akt phosphorylation and glucose 
uptake as readouts. Figure 9a shows that insulin induces a 
robust increase in  AktSer473 phosphorylation/activation that is 
blunted significantly (by ~ 58%) in myotubes that have been 
subject to GLC/PA oversupply (Fig. 9b). Associated with 
this loss in Akt-directed insulin, signalling was a substantial 
loss in insulin-stimulated glucose uptake (Fig. 9c). However, 
Fig. 7  Effect of suppressing NFkB activation in response to cellular 
fuel overloading on mitochondrial morphology, mitochondrial pro-
teins and gene expression. L6 myotubes were incubated with GLC 
(5 mM), PA (0.4 mM), 2DG (5 mM) and BI605906 (10 μM) for 16 h 
in the combinations indicated in the various experimental data panels 
prior to a analysis and quantification of mitochondrial morphology 
using Mitotracker green (Mitospy) by confocal microscopy (the scale 
bar represents 5 μm), b mitochondrial DNA copy number by qPCR, 
c citrate synthase (CS) activity and (d, e), analysis of mitochondria 
protein and mRNA abundance (UCP3, ANT1, PGC1α, SDHA, and 
COX4.1) which was normalised to GAPDH. All graphical bar data 
are presented as mean ± SEM from four separate experiments. Aster-
isks indicate a significant change (P < 0.05) to the GLC alone condi-
tion
Proinflammatory NFkB signalling promotes mitochondrial dysfunction in skeletal muscle in…
1 3
cotreatment of fuel-loaded myotubes with BI605906 or 
expression of the IκBαS32A/S36A super-repressor (Fig. 9d) 
not only mitigates the reduction in insulin-stimulated Akt 
phosphorylation (Fig. 9a, b, d, e), but also partially rescues 
the loss in hormone-stimulated glucose uptake (Fig. 9c, f).
Discussion
We have previously shown that heightened NFkB signalling 
associated with sustained nutrient oversupply, as occurs dur-
ing obesity, plays an important role in lipid-induced insulin 
resistance and metabolic dysfunction in skeletal muscle both 
in vitro and in vivo [17]. Precisely how an increase in NFkB 
signalling mechanistically links to changes in muscle insulin 
action is poorly understood, but we postulate that distur-
bances in mitochondrial homeostasis, driven by an increase 
in proinflammatory signalling, may potentially represent an 
important component within this link. This proposition is 
based on the view that whilst mitochondria play a crucial 
role in balancing energy supply with demand under nor-
mal circumstances, they become functionally compromised 
when supply of metabolic fuel chronically exceeds cellu-
lar energy demand. Our results indicate that the sustained 
oversupply of both GLC and PA imposes a major substrate 
burden on mitochondria in L6 myotubes and that this pro-
motes (1) a reduction in mitochondrial respiratory capacity, 
(2) reduced expression of key mitochondrial proteins, (3) 
increased generation of ROS and (4) increased mitochon-
drial fragmentation and mitophagy. It is also important to 
highlight that these observations are not just restricted to 
L6 myotubes, but can also be demonstrated in LHCN-M2 
myotubes; a myogenic cell line obtained from skeletal mus-
cle of a healthy male human subject (Supplementary Fig. 
S5). These nutrient-induced changes collectively signal a 
marked loss in mitochondrial integrity/function that impact 
negatively upon myocellular energy metabolism and, by 
extension, upon processes involved in fuel utilisation, such 
as glucose uptake and its regulation by insulin. Strikingly, 
our data indicate that pharmacological or genetic inhibi-
tion of the IKK–NFkB axis not only obviates detrimental 
changes in mitochondrial morphology and function, but also 
helps ameliorate disturbances in insulin signalling and insu-
lin-dependent glucose uptake. Furthermore, allied to these 
observations, it is worth stressing that withholding either 
GLC or PA from the media or inhibiting GLC use as a meta-
bolic fuel in the presence of PA not only averts activation of 
the NFkB pathway but antagonises mitochondrial fragmen-
tation and the loss in respiratory function (Figs. 1b, 3a, 4a). 
These findings imply that whilst myotubes can efficiently 
Fig. 8  Effects of cellular fuel overloading on mitophagy and upon 
proteins linked to mitochondrial dynamics. Wild type L6 myotubes or 
those stably expressing a retroviral vector encoding a GFP–mCherry–
Fis1 mitophagy reporter were incubated with GLC (5  mM), PA 
(0.4 mM) and BI605906 (10 μM) for 16 h as indicated prior to: a sub-
cellular fractionation and isolation of a cytosolic and mitochondrial-
enriched membrane fraction for immunoblotting with antibodies to 
proteins shown. b–e Fixing and confocal imaging to visualise and f 
quantifying (using the Volocity software) mitophagy in L6 myotubes. 
Data (mean ± SEM) in (f) are from five separate experiments. Aster-
isks indicate a significant change (P < 0.05) between the indicated 
bars. Boxed sections in panels b, c, d and e have been expanded to 
highlight mitophagic particles, some of which are depicted by the 
white arrow heads
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metabolise GLC (5 mM) or PA (0.4 mM) when presented 
independently at the concentrations indicated, their com-
bined carbon load appears to overwhelm the respiratory 
capacity of myotubes, especially if it is not matched by any 
increase in energy demand. Under these circumstances, the 
over provision of fatty acids leads to their incomplete oxi-
dation and accumulation as short chain acyl-carnitines  and 
their greater partitioning into lipotoxic fatty acid derivatives 
(e.g., DAG and ceramide) that have been implicated in the 
development of muscle insulin resistance [6, 11, 37–39]. 
The production of ceramide and certain DAG species may, 
in turn, feedback to further suppress the activity of respira-
tory chain complexes [40, 41], which, associated with the 
reduced expression of succinate dehydrogenase (complex II) 
that is induced in response to chronic fuel excess, is likely 
to impair electron transfer within the respiratory chain. This 
proposition is supported by our finding that uncoupled res-
piration in the presence of FCCP was markedly lower in 
myotubes incubated with GLC/PA than those treated with 
either nutrient alone (Fig. 1e) It is, therefore, plausible that 
the observed perturbations in mitochondrial homeostasis 
seen in this study may, in part, be a consequence of cellu-
lar lipotoxicity initiated by the accumulation of molecules 
such as DAG and ceramide that would be associated with 
sustained oversupply of fatty acids.
Numerous studies have shown that saturated fatty acids, 
such as PA, have the capacity to induce IKK–NFkB signal-
ling and can do so via a number of mechanisms including, 
for example, activation of toll-like receptors [42], MAP 
kinases (JNK and ERK) [25], excessive ROS generation [43] 
as well as by enhanced secretion of inflammatory cytokines 
(e.g., TNFα, IL-1β, and IL-6) that act via their respective 
cell surface receptors [44]. Whilst evidence exists associat-
ing these inflammatory cytokines with impaired mitochon-
drial function in some cell types [45, 46], studies linking 
classical NFkB signalling to mitochondrial dysfunction in 
Fig. 9  Effects of suppressing NFkB signalling in response to cellular 
fuel overloading on insulin-stimulated PKB phosphorylation and glu-
cose uptake in L6 myotubes a–c L6 myotubes were incubated for 16 h 
with GLC (5 mM) or PA (0.4 mM) alone or with PA (0.4 mM)/GLC 
(5  mM) together in the absence or presence of BI605906 (10  μM). 
Alternatively, d–f muscle cells were subject to incubation with GLC 
and PA as indicated having been infected with an adenoviral vector 
expressing HA-tagged non-phosphorylatable IkBα (S32A/S36A) or 
one expressing an empty vector (EV) prior to acute stimulation with 
insulin (20  nM) for 15  min (Akt signalling experiments) or insulin 
(100  nM) for 20  min for glucose uptake studies. Following insulin 
stimulation, cells were either lysed for immunoblotting using antibod-
ies to proteins indicated (a, d) or used for assay of glucose uptake. 
The data are mean ± SEM. from 5 separate experiments. Asterisks 
indicate a significant change (P < 0.05) between the indicated bars
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muscle cells in response to fuel over loading are extremely 
sparse. However, one potential mechanism by which NFkB 
may modulate myocellular energy metabolism is via its well-
established role as a regulator of gene expression [47]. Nota-
ble NFkB gene targets include those encoding mitochondrial 
proteins or transcription factors that regulate expression 
of key mitochondrial genes. For example, recent work in 
human glioblastoma cells has highlighted that activated 
NFkB can bind to two response elements within the gene 
promoter of the ADP/ATP translocase, ANT-1, resulting in 
its reduced expression and concomitant decline in mitochon-
drial ATP production [48]. NFkB activation also represses 
the activity of PGC1α [49], which functions as a critical 
regulator of not only mitochondrial biogenesis/respiration 
but expression of nuclear respiratory factors (NRFs) that, 
in turn, modulate expression of mitochondrial proteins such 
as UCP3 and SDHA [50–52]. An increase in mitochondrial 
biogenesis/content may serve as an initial response to nutri-
ent excess, but such compensation typically fails in the face 
of sustained nutrient oversupply. This compensation pro-
cess appears to be very short lived in our in vitro myotube 
cultures as whilst we observe an initial increase in the gene 
expression of PGC1α, SDHA, ANT-1, and UCP3 (during 
the first 4 h of nutrient oversupply), we find that this rapidly 
declines over the succeeding 20 h myotube incubation period 
with GLC and PA (Supplementary Fig. S7). This decline 
correlates with an associated increase in NFkB activation as 
judged by the loss in IkBα and increased expression of IL-6 
that is observed from 4 h onwards in myotubes (Supplemen-
tary Fig. S7). The notion that these events are likely to be 
linked is supported by our finding that the targeted inhibition 
of the IKK–NFkB axis helps mitigate the loss of these mito-
chondrial proteins and the associated decline in respiratory 
function. Assessing whether the changes in PGC1α, SDHA, 
ANT-1 and UCP3 that we see in myotubes in response to 
fuel overloading are primarily a consequence of a reduction 
in gene expression or also involve post-transcriptional modu-
lation of processes such as protein synthesis and degradation 
represent important investigative goals of future work.
Another critical regulator of mitochondrial metabolism 
and cellular responsiveness to insulin is ROS [53]. Mito-
chondria are major sources of ROS and generated as a con-
sequence of electron “slippage” within the electron transport 
chain (ETC) to oxygen during OXPHOS [54]. ROS gener-
ated by the ETC are considered important for preserving 
the normal biological functionality of the respiratory chain. 
However, under certain circumstances, including mitochon-
drial substrate overload, sustained and elevated generation 
of ROS supersedes the capacity of anti-oxidant defence 
mechanisms leading to increased oxidative stress. Com-
ponents of the respiratory chain are highly susceptible to 
oxidative damage and this not only reduces the fidelity and 
operational efficiency of the ETC, but also results in further 
augmentation in ROS generation that effectively establishes 
a viscous cycle driving greater mitochondrial dysfunction 
[55]. Our findings reveal that heightened ROS production 
is indeed a feature of mitochondrial substrate overload 
(Fig. 5) and that this occurs despite an attendant increase in 
the expression of SOD2, GPX1 and catalase (Supplementary 
Fig. S2) that most likely represent a cellular stress response 
designed to limit oxidative stress. Intriguingly, whilst expos-
ing GLC/PA-overloaded myotubes to mitochondrial targeted 
anti-oxidants such as Mitotempo restrains superoxide accu-
mulation (Supplementary Fig. S1) and confers protection 
against mitochondrial fragmentation (Supplementary Fig. 
S4), treatment of myotubes with either Mitotempo or MitoQ 
could not rescue the decline in mitochondrial respiratory 
capacity induced by fuel overloading. This observation is 
most likely explained by the fact that neither anti-oxidant 
was able to mitigate activation of the IKK–NFkB pathway 
that we believe initiates the loss of key mitochondrial pro-
teins, such as SDHA, UCP3, and ANT-1 in fuel-overloaded 
myotubes (Supplementary Fig. S4). SDHA is a critical 
component within both the TCA cycle and ETC, and conse-
quently, its loss will impact negatively upon both mitochon-
drial processes. Whilst the precise functional role of UCP3 
remains uncertain, its expression in cultured myotubes and 
rodent skeletal muscle has been linked to modulation of 
fatty acid oxidation [56–58], mitochondrial integrity, and to 
management of ROS/oxidative stress [59–62]. Likewise, in 
addition to catalysing the exchange of cytoplasmic ADP for 
mitochondrial ATP, ANT-1 can mediate fatty acid-induced 
uncoupling via its ability to transfer fatty acid anions across 
the inner mitochondrial membrane [63]. Consequently, mild 
uncoupling mediated by both UCP3 and ANT-1 may be ben-
eficial in protecting mitochondria against the reducing pres-
sure created by transient increases in fuel supply and, by 
doing so, restraining the excessive generation/accumulation 
of ROS that may otherwise promote oxidative damage and 
impair skeletal muscle insulin sensitivity. The fact that sup-
pressing NFkB activation in fuel-overloaded myotubes with 
BI605906 or 2DG antagonises loss of UCP3 and ANT-1 and 
that, under these circumstances, we not only see a meas-
urable increase in mitochondrial proton leak, but observe 
improved insulin sensitivity in L6 myotubes (Fig. 9) and 
in muscle of obese Zucker rats [17] is fully congruent with 
this view. Furthermore, it is noteworthy that the notion that 
mitochondrial expression/activity of ANT-1 may influence 
insulin sensitivity of muscle cells is supported by studies 
in cultured C2C12 myotubes, in which partial silencing of 
ANT-1 results in reduced cellular sensitivity to fatty acid-
induced uncoupling and a significant reduction in insulin-
stimulated glucose uptake [63].
In skeletal muscle, reduced mitochondrial respiration 
has also been linked to aberrant control of mitochondrial 
dynamics [64–67]. Increased exposure of myotubes to PA 
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and fatty acid derivatives such as ceramide promote a low 
mitochondrial fusion to fission ratio resulting in fragmented, 
discontinuous mitochondria that not only exhibit dimin-
ished capacity for respiration and ATP synthesis, but also 
is thought to be causally linked to impaired insulin sensitiv-
ity and metabolic function [66–68]. Consistent with these 
observations, GLC/PA overloading of L6 myotubes in our 
studies induced a profound morphological change in mito-
chondria from an elongated/tubular network to one that is 
highly fragmented, indicative of a dynamic shift towards 
greater fission. The increase in Drp1 (a profission protein) 
and reduction in MFN2 (a profusion protein) that we see 
within a mitochondrial-enriched membrane fraction is 
fully consistent with this view. Strikingly, pharmacological 
inhibition of the IKK–NFkB axis in GLC/PA-overloaded 
myotubes not only suppresses the relative changes in Drp1 
and MFN2, but reduces fragmentation of the mitochondrial 
network, in which, significantly, we find was also associ-
ated with amelioration in cellular respiratory capacity and 
insulin action. Since Mitotempo is able to partially restore 
the tubular mitochondrial network, but not the loss in res-
piratory capacity in fuel-overloaded myotubes (Supplemen-
tary Fig. S4), we postulate that increased fission is likely 
to be secondary to the increased production of ROS that 
stems from mitochondrial dysfunction induced by activa-
tion of the NFkB pathway. It is also noteworthy that whilst 
our studies indicate that the activation of canonical NFkB 
signalling initiated in response to fuel overloading pro-
motes mitochondrial fragmentation, this process can also 
be influenced by non-canonical NFkB signalling, which is 
independent of IKKβ and IKKγ (NEMO) but dependent on 
IKKα dimers. Although we saw no differences in OPA-1 
expression in our mitochondrial-enriched membrane frac-
tions from fuel-overloaded L6 myotubes, MEF cells lacking 
IKKα (but not IKKβ) exhibit reduced cellular expression of 
OPA-1 and display enhanced mitochondrial fission [69]. It 
is also noteworthy that the activation of the classical NFkB 
pathway in C2C12 myotubes can result in suppressed IKKα 
expression and that this has implications for expression of 
OXPHOS genes [70]. Regardless of the stimulus promot-
ing a shift towards greater fission, whilst some of the frag-
mented mitochondria may retain their functional capacity, 
the structural integrity of others is likely to be compromised 
(as reflected by an overall reduction in cellular respiratory 
capacity) and, if not recoverable, will be targeted for clear-
ance by mitophagy. Consistent with this view, we observed a 
significant increase in the number of mitophagic particles in 
myotubes subjected to GLC/PA loading, and in line with the 
protective effects, we suggest that the inhibition of canonical 
NFkB signalling confers upon mitochondrial integrity and 
function; this increase in mitophagy was blunted in myo-
tubes that had been cotreated with BI606906. It is worth 
stating that the observed increase in mitophagy and the 
associated loss of key mitochondrial proteins (SDHA, ANT-
1, and UCP3) that we see in fuel-overloadeded myotubes 
occur despite their being no significant change in mitochon-
drial DNA or citrate synthase activity. One potential expla-
nation for this apparent paradox is that whilst our mitophagy 
reporter assay is highly sensitive and the loss in mitochon-
drial proteins may be accounted for by a reduction in the 
transcription and/or translation of their respective genes and 
products, analysis of mitochondrial DNA may also capture 
that present within mitochondria during the early stages of 
the mitophagic process. If so, this would lessen any potential 
differences in mitochondrial DNA between the treatments 
that we have performed.
In conclusion, our findings indicate that muscle cells sub-
jected to sustained oversupply of metabolic fuel exhibit an 
increase in proinflammatory NFkB signalling that is mech-
anistically linked to diminished mitochondrial function as 
evidenced by our ability to antagonise the marked decline in 
respiratory capacity, expression of key mitochondrial maker 
proteins and the increased fission and mitophagy by phar-
macological or genetic repression of the IKK–NFkB axis. 
Whilst very recent work has shown that sustained inhibi-
tion of NFkB can adversely affect muscle development and 
mitochondrial function during early life its repression has 
no detrimental effect in adult muscle [71]. Consequently, 
our observations would imply that therapeutic strategies 
that help restrain NFkB activation as seen during circum-
stances of energy excess, such as obesity and age-onset Type 
II diabetes, may help counter disturbances in mitochondrial 
homeostasis and impart beneficial effects upon skeletal mus-
cle insulin sensitivity.
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